Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-29

Clinical Trial Update: The Effective Treatment of Oral Helicobacter Pylori With the Success Rate of Gastric Eradication [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating an oral treatment for Helicobacter pylori infection has completed, reporting gastric eradication outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ameritek USA | Conditions: Oral Helicobacter Pylori | Phase 1, Phase 2 | Status: COMPLETED